Sangeeta Khare
Company: US Food & Drug Administration (FDA)
Job title: PI
Seminars:
Current Approaches, Challenges & Opportunities to Establish Microbiome as a Risk Assessment Tool 4:00 pm
Exploring how exposures to xenobiotics may impact the gastrointestinal barrier and lead to disruptions in the abundance and function of microbiome Discussing ongoing approaches, challenges, and opportunities to establish science-based minimum standards for conducting risk assessment of such products Using animal and non-animal modelsRead more
day: Conf Day 1